Esmolol in the management of epinephrine- and cocaine-induced cardiovascular toxicity.
Pollan
S
S
University of Pittsburgh, Veterans Administration Medical Center, Pennsylvania 15240.
Tadjziechy
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000188:drug therapy; D003042:Cocaine / Q000009:adverse effects* / Q000627:therapeutic use; D004837:Epinephrine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009298:Nasal Polyps / Q000601:surgery; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D003042:Cocaine; C036604:esmolol; D004837:Epinephrine